Besides CDKN2A, another three genes including EPHA5, FANCM, and MAP3K1 showed significantly higher mutation rates in sarcomatoid HCC than non‐sarcomatoid HCC. This evidence concerns the gene CDKN2A and hepatocellular carcinoma.